Opko Health, Inc. - Common Stock (OPK)

Late Friday, the company said the U.S.-China tariffs will have a material impact on anticipated sales of U.S. products into China.

OPK earnings call for the period ending December 31, 2024.

Insider trades are a telling indicator of C-Suite conviction but aren't always the signal for investors they could be. Only two of these stocks are good buys.

OPK earnings call for the period ending September 30, 2024.

OPK earnings call for the period ending June 30, 2024.

Opko Health shares are trading higher Thursday after the company announced a $100 million share repurchase program. Here's a look at what to know:

Opko Health shares are trading higher after-hours Wednesday. The company announced it has entered into a $250 million non-dilutive note purchase agreement with HealthCare Royalty (HCRx).

One of the best ways to spot opportunity in penny stocks to buy is by following insiders. Here are three to consider.

OPK earnings call for the period ending March 31, 2024.

OPK stock results show that OPKO Health missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Labcorp acquires certain operations of Opko Health subsidiary BioReference Health. The assets Labcorp is acquiring generate about $100 million in annual revenue, with the transaction valued at $237.5 million.

Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of $1.13 per share, compared to market expectations for a loss of 77 cents per share.